CHOSA Oncology AB Sustainability Reports
CHOSA Oncology AB is a biotechnology company focused on developing personalized cancer treatments, specializing in diagnostics and drug formulation optimization. Its primary asset is the Platin-DRP companion diagnostic system designed to predict clinical responses to platinum-based chemotherapy treatments.
Sector: Manufacturing
Country: Sweden
Exchange: Spotlight Stock Market
LEI: 5493002SFL9YXB0A0027
FIGI: BBG00BZY17V1
1 reports from 2022 to 2022
